Clinical Trial Update: MYLUNG Consortium Study Protocol 2

View source ↗

Summary

Update on the MYLUNG Consortium Study Protocol 2 for non-small cell lung cancer; the study is listed as active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: US Oncology Research | Conditions: Carcinoma, Non-Small-Cell Lung | Status: ACTIVE_NOT_RECRUITING